RxDoctor Payments Data

Vincent Rodriguez Bury, MD

Urology · Carolina, PRNPI 1003221458

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (49.9%), travel and lodging and education — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 70.5% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $1,633 and has fallen 85.4% since, to $238 in 2025. That places this record below the midpoint for urology clinicians in PR, where the typical reported total is $2,115.

$2,551in general payments, 2019–2025

Across 35 payments — averaging $72.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$2K
  • Medtronic$263
  • Merck$193
  • Endo USA, Inc.$130
  • Johnson And Johnson International$95
  • Ferring Pharmaceuticals Inc.$31
  • plus $42 from 3 others

What the payments were for

  • Travel & lodging$1,26450%
  • Food & beverage$1,27450%
  • Education$131%

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific17$1,798
Medtronic3$263
Merck8$193
Endo USA, Inc.1$130
Johnson And Johnson International1$95
Ferring Pharmaceuticals Inc.2$31
Tolmar, Inc.1$17
Pfizer1$13
PBG Puerto Rico LLC1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,551 in reported general payments places this provider in the 50th percentile of 122 urology providers in Puerto Rico.

See all urology providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$14,211
Medicare patients
36
Services billed
132

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tolterodine Tartrate ErTolterodine Tartrate651$47,400
Tamsulosin Hcl1,282$22,018
Finasteride690$14,779
Cefadroxil379$2,461
Ketorolac Tromethamine51$1,605
Cephalexin191$1,420
Silodosin26$1,318
Alfuzosin Hcl ErAlfuzosin Hcl96$1,245
Potassium Citrate ErPotassium Citrate59$1,178
Ciprofloxacin Hcl137$804
Bethanechol Chloride18$634
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip28$576
Clotrimazole32$525
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav30$498
Sildenafil Citrate47$471

Paid to pharmacies, not to this prescriber.

Other urology in Carolina

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →